Kisspeptin

Steady

Kisspeptin appears in 3,829 indexed publications going back to 2012, including 213 in the past twelve months. 24 registered trials appear on ClinicalTrials.gov.

3,829
Indexed publications
213
Past 12 months, against 230 the year before
24
Registered clinical trials
2,484
Monthly readers on Wikipedia, up 4%
Research Activity

Publication history

How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.

20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
20154
201610
201713
201831
201948
202072
202191
2022148
2023121
2024138
2025174
2026146
Public Attention

Who is looking it up

Monthly readers of the Kisspeptin article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.

2025-082026-07
Clinical Trials

The registered pipeline

Early Phase 1
0
Phase 1
10
Phase 2
4
Phase 3
1
Phase 4
0

Phase distribution across the most recently updated registered trials.

References

Most recent work

The newest indexed records mentioning Kisspeptin, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.

  1. 2026-06-30·Molecular and cellular endocrinology

    The kisspeptin analog C6 elicits greater tachyphylaxis and transcriptional activation than kisspeptin-10 and -54

    Robert V, Lomet D, Dardente H et al.

  2. 2026-05-15·Toxicology

    Atrazine alters kisspeptin signaling and downstream neuroendocrine regulation following embryonic exposure in zebrafish

    Stradtman SC, Sathisaran U, Dierolf BK et al.

  3. 2026-08-01·Anticancer research

    Kisspeptin Signaling Suppresses HRas<sup>G12V</sup>-induced Tumor Growth and Metastasis by Inhibiting SP1-dependent N-cadherin Expression in NIH3T3 Cells

    Hwang HH, Cho SG. et al.

  4. 2026-06-23·Neuropeptides

    Kisspeptin-54 attenuates acute lung injury in septic mice through AMPK-mediated suppression of NLRP3 inflammasome

    Wang X, Zou Z, Huang H. et al.

  5. 2026-06-11·Cytotechnology

    Exogenous Kisspeptin-10 inhibits ovarian cancer progression through targeting the SP1-hTERT-ZEB1 regulatory axis

    Shah H, Thomas A, Pandya P. et al.

  6. 2026-06-08·Current opinion in pediatrics

    Missense mutations in MKRN3 and central precocious puberty: a mutational approach to understanding protein function

    Franssen D, Kaiser UB. et al.

  7. 2026-05-14·Behavioural brain research

    Neurotransmitter and neuromodulator imbalance in kisspeptin/GnRH regulation in rodent models of polycystic ovary syndrome and its implications for mental health disorders: A systematic review

    Dutra JB, Gregorio T, Lorenzon F et al.

  8. 2026-03-27·Tissue & cell

    Kisspeptin-54 confers renal protection in diabetic nephropathy by ameliorating endothelial permeability through ZEB1 inhibition

    Gao L, Lv Q, Wang Y et al.

In the Catalogue

Kisspeptin available from Polaris Research

Supplied as research materials for laboratory use. Free express delivery Australia wide.

Sources

Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-08-02.